Performance of novel clinical case definitions for respiratory syncytial virus infections in young infants: a latent class analysis Pubblico

Abstract

Background: Respiratory syncytial virus (RSV) is a major cause of pediatric morbidity and mortality worldwide. Appropriate case definitions are needed to accurately assess disease burden and evaluate novel RSV therapeutics and vaccines. Limited data exist on performance of RSV case definitions among young infants or in high-resource settings.

 

Methods: We used data collected on infants <6 months of age tested for RSV as part of routine clinical care at Children’s Healthcare of Atlanta between January 2010-December 2015. We evaluated sensitivity, specificity, positive (PPV) and negative predictive values (NPV) of clinical features, existing case definitions used by the World Health Organization (WHO), and alternative definitions we constructed using latent class analyses (LCA) to detect laboratory-confirmed RSV infection.

 

Results: Among 565 infants tested for RSV, 161 (28.5%) had laboratory-confirmed RSV infection. Among all case definitions evaluated, WHO-acute respiratory infection (ARI) (“cough or sore throat or shortness of breath or coryza, and a clinician’s judgment that illness is due to infection”) was the most sensitive [98.1%, 95% confidence interval (CI), 96.1–100.0, NPV 96.3%, 95% CI 92.2–100.0]. The definition developed through LCA (cough and shortness of breath and coryza and wheeze and poor feeding and chest in-drawing) was the most specific (95.8%, 95% CI 93.8–97.8; PPV 51.4%, 95% CI 34.9–68.0).

 

Conclusions: The WHO ARI definition was the most sensitive for detecting laboratory-confirmed RSV infections among infants aged <6 months. However, alternative case definitions can confer higher specificity. Appropriate case definitions will vary depending on the context and setting in which they are utilized.    

Table of Contents

 

Chapter 1: Definition of terms.................................................................................................................................................... 1

CHAPTER 2: Review of the literature....................................................................................................................................... 2

2.1 RSV epidemiology, morbidity, and mortality in pediatric populations............................ 2

2.2 RSV-associated healthcare costs in pediatric populations.......................................................... 4

2.3 Development of an RSV vaccine......................................................................................................................... 6

2.4 Evaluation of potential RSV case definitions........................................................................................... 6

2.5 Summary, problem, and purpose statement...................................................................................... 11

Chapter 3: Manuscript................................................................................................................................................................... 12

Abstract.......................................................................................................................................................................................... 12

Introduction............................................................................................................................................................................... 14

Methods......................................................................................................................................................................................... 15

Sample study and design............................................................................................................................. 15

Definitions.................................................................................................................................................................. 16

Statistical analyses.............................................................................................................................................. 17

................................... Results..........................................................................................................................................................18

.................................. Discussion...................................................................................................................................................21

.................................. Conclusion..................................................................................................................................................24

............................. Tables and Figures..................................................................................................................................25

Table 1.......................................................................................................................................................................... 25

Table 2.......................................................................................................................................................................... 26

Table 3.......................................................................................................................................................................... 27

Table 4.......................................................................................................................................................................... 28

Table 5.......................................................................................................................................................................... 29

Figure 1........................................................................................................................................................................ 30

Box 1............................................................................................................................................................................... 31

Supplemental Table 1..................................................................................................................................... 32

Supplemental Table 2..................................................................................................................................... 33

Supplemental Table 3..................................................................................................................................... 34

References................................................................................................................................................................................... 35

Chapter 4: Conclusion and recommendations......................................................................................................... 38

 

About this Master's Thesis

Rights statement

• Permission granted by the author to include this thesis or dissertation in this repository. All rights reserved by the author. Please contact the author for information regarding the reproduction and use of this thesis or dissertation.

School	Rollins School of Public Health
Department	Hubert Department of Global Health
Degree	M.P.H.
Submission	Master's Thesis
Language	English
Research Field	Health Sciences, Public Health Health Sciences, Epidemiology
Parola chiave	case definitions high-income setting infants latent class analysis English respiratory syncytial virus
Committee Chair / Thesis Advisor	Omer, Saad, Emory University
Partnering Agencies	Hospital or other health care provider

Ultima modifica

Primary PDF

Thumbnail	Title	Date Uploaded	Actions
	Performance of novel clinical case definitions for respiratory syncytial virus infections in young infants: a latent class analysis ()	2018-04-24 12:16:25 -0400	Press to Select an action Download

Supplemental Files

Thumbnail	Title	Date Uploaded	Actions